FDA considering structure for Office of Chemistry that cuts across reviewing divisions.
This article was originally published in The Tan Sheet
Executive Summary
FDA OFFICE OF CHEMISTRY ORGANIZED HORIZONTALLY ACROSS DRUG DIVISIONS is one of the models for the proposed new office being considered by the Center for Drug Evaluation & Research, CDER Associate Director for Science and Medical Affairs Roger Williams, MD, said at the National Association of Pharmaceutical Manufacturers' annual meeting in Las Croabas, Puerto Rico on Feb. 1.